BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Daiichi Sankyo
Harvard Business School
US Army

Generated: December 15, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

When do Dextroamphetamine Sulfate patents expire, and when can generic versions of Dextroamphetamine Sulfate launch?

Dextroamphetamine Sulfate is a drug marketed by Able, Actavis Elizabeth, Mallinckrodt, Mayne Pharma, Mylan Pharms Inc, Nesher Pharms, Vintage Pharms, Outlook Pharms, Tris Pharma Inc, Aurolife Pharma Llc, Avanthi Inc, Barr, Epic Pharma Llc, Halsey, Idt Australia Ltd, Lannett, Mast Mm, Mikart, Novel Labs Inc, Purepac Pharm, Sandoz, Sunrise Pharm Inc, Vintage Pharms Llc, and Vitarine. and is included in thirty NDAs.

The generic ingredient in DEXTROAMPHETAMINE SULFATE is dextroamphetamine sulfate. There are seventeen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the dextroamphetamine sulfate profile page.


Drug patent expirations by year for DEXTROAMPHETAMINE SULFATE


Medical Subject Heading (MeSH) Categories for DEXTROAMPHETAMINE SULFATE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
MikartDEXTROAMPHETAMINE SULFATEdextroamphetamine sulfateTABLET;ORAL090533-002Oct 25, 2011AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
HalseyDEXTROAMPHETAMINE SULFATEdextroamphetamine sulfateTABLET;ORAL083930-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Nesher PharmsDEXTROAMPHETAMINE SULFATEdextroamphetamine sulfateTABLET;ORAL040367-001Oct 31, 2002DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MikartDEXTROAMPHETAMINE SULFATEdextroamphetamine sulfateTABLET;ORAL090533-006Oct 25, 2011RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Nesher PharmsDEXTROAMPHETAMINE SULFATEdextroamphetamine sulfateTABLET;ORAL206588-002Mar 28, 2016AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Sunrise Pharm IncDEXTROAMPHETAMINE SULFATEdextroamphetamine sulfateTABLET;ORAL210059-001Oct 18, 2017AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrDEXTROAMPHETAMINE SULFATEdextroamphetamine sulfateTABLET;ORAL040361-001Jan 31, 2001AARXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Idt Australia LtdDEXTROAMPHETAMINE SULFATEdextroamphetamine sulfateTABLET;ORAL085370-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
BarrDEXTROAMPHETAMINE SULFATEdextroamphetamine sulfateTABLET;ORAL040361-002Jan 31, 2001AARXNoYes► Subscribe► Subscribe► Subscribe► Subscribe
AbleDEXTROAMPHETAMINE SULFATEdextroamphetamine sulfateCAPSULE, EXTENDED RELEASE;ORAL076814-001Aug 25, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
Argus Health
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: